Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article - Biomedical Research (2018) Volume 29, Issue 2

The effect and different expressions of t lymphocyte before and after immunotherapy in patients with recurrent spontaneous abortion

Objective: To investigate the different serum expressions of CD3+, CD4+ and CD8+ in the peripheral blood among the patients with Recurrent Spontaneous Abortion (RAS) before and after immunization therapy and to evaluate the clinical effects and pregnancy outcomes.

Methods: 157 RAS patients with negative blocking antibody in our hospital were enrolled into the study and treated with immunity therapy from September 2015 to August 2017. The blocking efficiency of T lymphocytes (CD3+, CD4+ and CD8+) in peripheral blood of patients with the lymphocyte of patients’ husband (or unrelated healthy male) as antigen target were measured by double fluorescent marker flow cytometric analysis technique.

Results: After treatment, the serum blocking efficiency of CD3+, CD4+, CD8+ were higher than before treatment, P<0.05. And the serum blocking efficiency of CD3+, CD4+, CD8+ in 37 RAS patients with positive blocking antibody after treatment were higher than before treatment or 121 RAS patients with negative blocking antibody, P<0.05. Besides, there were 18 RAS patients (14.88%) who had negative blocking antibody after treatment with successful pregnancy and 12 RAS patients (33.33%) who had positive blocking antibody after treatment with successful pregnancy.

Conclusion: Active immunotherapy can improve the blocking efficiency of CD3+, CD4+ and CD8+ in peripheral blood of recurrent spontaneous abortion patients there for helping pregnancy, which would be recommended for the clinical used as an effective treatment.

Author(s): Zhao Yaning, Cao Jing, Gao Weihua

Abstract Full Text PDF